NO20053825D0 - Thienopyridazinoner og deres anvendelse ved modulering av autoimmune sykdommer. - Google Patents

Thienopyridazinoner og deres anvendelse ved modulering av autoimmune sykdommer.

Info

Publication number: NO20053825D0
Authority: NO; Norway
Prior art keywords: thienopyridazinones; autoimmune diseases; modulating autoimmune; modulating; diseases
Prior art date: 2003-01-17

Application number

NO20053825A

Other languages

English (en)

Other versions

NO20053825L (no

Inventor

Anthony Howard Ingall

Simon David Guile

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-01-17

Filing date

2005-08-15

Publication date

2005-08-15

2003-01-17 Priority claimed from SE0300117A external-priority patent/SE0300117D0/xx

2003-01-17 Priority claimed from SE0300118A external-priority patent/SE0300118D0/xx

2005-08-15 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2005-08-15 Publication of NO20053825D0 publication Critical patent/NO20053825D0/no

2005-10-17 Publication of NO20053825L publication Critical patent/NO20053825L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Virology (AREA)
Physical Education & Sports Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Oncology (AREA)
Endocrinology (AREA)
Rheumatology (AREA)
Neurosurgery (AREA)
Hematology (AREA)
AIDS & HIV (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Emergency Medicine (AREA)
Tropical Medicine & Parasitology (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Ophthalmology & Optometry (AREA)
Transplantation (AREA)

NO20053825A 2003-01-17 2005-08-15 Thienopyridazinoner og deres anvendelse ved modulering av autoimmune sykdommer. NO20053825L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE0300117A SE0300117D0 (sv)	2003-01-17	2003-01-17	Novel Compounds
SE0300118A SE0300118D0 (sv)	2003-01-17	2003-01-17	Novel Compounds
PCT/SE2004/000053 WO2004065395A1 (en)	2003-01-17	2004-01-15	Thienopyridazinones and their use in modulation of autoimmune disease

Publications (2)

Publication Number	Publication Date
NO20053825D0 true NO20053825D0 (no)	2005-08-15
NO20053825L NO20053825L (no)	2005-10-17

Family

ID=32775326

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20053825A NO20053825L (no)	2003-01-17	2005-08-15	Thienopyridazinoner og deres anvendelse ved modulering av autoimmune sykdommer.

Country Status (15)

Country	Link
US (2)	US7393854B2 (no)
EP (1)	EP1587811A1 (no)
JP (1)	JP2006515880A (no)
KR (1)	KR20050092761A (no)
AU (1)	AU2004206011B2 (no)
BR (1)	BRPI0406782A (no)
CA (1)	CA2512136A1 (no)
IL (1)	IL169369A0 (no)
IS (1)	IS7962A (no)
MX (1)	MXPA05007495A (no)
NO (1)	NO20053825L (no)
NZ (1)	NZ541218A (no)
PL (1)	PL378221A1 (no)
RU (1)	RU2332420C2 (no)
WO (1)	WO2004065395A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0117583D0 (en)	2001-07-19	2001-09-12	Astrazeneca Ab	Novel compounds
GB0118479D0 (en) *	2001-07-28	2001-09-19	Astrazeneca Ab	Novel compounds
SE0300120D0 (sv)	2003-01-17	2003-01-17	Astrazeneca Ab	Novel compounds
EP1587811A1 (en) *	2003-01-17	2005-10-26	AstraZeneca AB	Thienopyridazinones and their use in modulation of autoimmune disease
SE0300119D0 (sv)	2003-01-17	2003-01-17	Astrazeneca Ab	Novel compounds
MX376059B (es) *	2013-10-21	2025-03-07	Genosco	Compuestos de pirimidina substituidos y su uso como inhibidores de la tirosina cinasa del bazo (syk).
UY36586A (es) *	2015-03-26	2016-10-31	Bayer Pharma AG	Heterociclilmetiltienouracilos y uso de los mismos

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6469014B1 (en) *	1997-05-28	2002-10-22	Astrazeneca Ab	Thieno[2,3-d] pyrimidinediones, their preparation and use in therapy
SE9702001D0 (sv) *	1997-05-28	1997-05-28	Astra Pharma Prod	Novel compounds
US6984644B2 (en) *	1997-05-28	2006-01-10	Astrazeneca Ab	Treatment of skin disorders using thieno[2,3-D]pyrimidinediones
TR200001603T2 (tr)	1997-12-05	2000-10-23	Astrazeneca Uk Limited	Yeni bileşikler
US6232320B1 (en)	1998-06-04	2001-05-15	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory compounds
US6233320B1 (en) *	1998-06-22	2001-05-15	Lucent Technologies Inc.	Method and apparatus for recording and playing back a conversation using a digital wireless phone
DK1107973T3 (da) *	1998-08-28	2004-02-23	Astrazeneca Ab	Hidtil ukendte thieno(2,3-D)pyrimidindioner, fremgangsmåde til deres fremstilling og anvendelse deraf i terapi
ATE272642T1 (de) *	2000-05-04	2004-08-15	Astrazeneca Ab	Thieno(2,3-d)pyrimidindione und ihre verwendung als pharmazeutische mittel
GB0117583D0 (en) *	2001-07-19	2001-09-12	Astrazeneca Ab	Novel compounds
GB0118479D0 (en) *	2001-07-28	2001-09-19	Astrazeneca Ab	Novel compounds
SE0300119D0 (sv) *	2003-01-17	2003-01-17	Astrazeneca Ab	Novel compounds
EP1587811A1 (en) *	2003-01-17	2005-10-26	AstraZeneca AB	Thienopyridazinones and their use in modulation of autoimmune disease
SE0300120D0 (sv) *	2003-01-17	2003-01-17	Astrazeneca Ab	Novel compounds

2004
- 2004-01-15 EP EP04702470A patent/EP1587811A1/en not_active Withdrawn
- 2004-01-15 NZ NZ541218A patent/NZ541218A/en unknown
- 2004-01-15 CA CA002512136A patent/CA2512136A1/en not_active Abandoned
- 2004-01-15 MX MXPA05007495A patent/MXPA05007495A/es active IP Right Grant
- 2004-01-15 BR BR0406782-7A patent/BRPI0406782A/pt not_active IP Right Cessation
- 2004-01-15 JP JP2006500751A patent/JP2006515880A/ja active Pending
- 2004-01-15 PL PL378221A patent/PL378221A1/pl not_active Application Discontinuation
- 2004-01-15 KR KR1020057013127A patent/KR20050092761A/ko not_active Ceased
- 2004-01-15 US US10/542,457 patent/US7393854B2/en not_active Expired - Fee Related
- 2004-01-15 WO PCT/SE2004/000053 patent/WO2004065395A1/en not_active Ceased
- 2004-01-15 AU AU2004206011A patent/AU2004206011B2/en not_active Ceased
- 2004-01-15 RU RU2005121492/04A patent/RU2332420C2/ru not_active IP Right Cessation
2005
- 2005-06-23 IL IL169369A patent/IL169369A0/en unknown
- 2005-07-27 IS IS7962A patent/IS7962A/is unknown
- 2005-08-15 NO NO20053825A patent/NO20053825L/no not_active Application Discontinuation
2008
- 2008-05-21 US US12/124,319 patent/US20080221131A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BRPI0406782A (pt)	2006-01-17
US20060135539A1 (en)	2006-06-22
RU2005121492A (ru)	2006-02-10
RU2332420C2 (ru)	2008-08-27
AU2004206011A1 (en)	2004-08-05
MXPA05007495A (es)	2005-09-21
JP2006515880A (ja)	2006-06-08
IL169369A0 (en)	2007-07-04
IS7962A (is)	2005-07-27
KR20050092761A (ko)	2005-09-22
WO2004065395A1 (en)	2004-08-05
AU2004206011B2 (en)	2007-07-12
PL378221A1 (pl)	2006-03-20
US20080221131A1 (en)	2008-09-11
CA2512136A1 (en)	2004-08-05
EP1587811A1 (en)	2005-10-26
NO20053825L (no)	2005-10-17
NZ541218A (en)	2008-05-30
US7393854B2 (en)	2008-07-01

Publication	Publication Date	Title
NO20040364L (no)	2004-03-29	Tienopyrimidindioner og deres anvendelse ved modulering av autoimmune sykdommer
DK1641822T3 (da)	2013-07-22	Heterologe il-17-a/f-polypeptider og terapeutiske anvendelser deraf.
DE60325514D1 (de)	2009-02-05	Ützten benutzeridentifikation und authentifikation
NO20053817D0 (no)	2005-08-12	Preparater og fremgangsmater for antiviral kombinasjonsterapi.
IS2844B (is)	2013-08-15	Varnarvírnet, varnarvirki búið til með netinu og notkunin á varnarvírnetinu við að búa til varnarvirki
IL231298A0 (en)	2014-04-30	Genetic products differentially expressed in tumors and the use thereof
DE10393673D2 (de)	2005-07-14	Wirbelkörperplatzhalter
DE10393091D2 (de)	2005-05-12	Wirbelkörperplatzhalter
ATE479437T1 (de)	2010-09-15	Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung
DK1738044T3 (da)	2009-03-23	Nöglekombinationseelement i nögleråemne og nögle
NO20043370L (no)	2004-09-28	N-pyrazinylfenylsulfonamider og deres anvendelse ved behandling av kemokinmedierte sykdommer
DK1675852T3 (da)	2009-05-25	Heterocykliske 7-amino-alkylidenyl-quinoloner og -naphthyridoner
DK1797269T3 (da)	2013-08-26	Multifunktionelt og bærbart sikkerhedssystem
IS7815A (is)	2005-04-20	3-Fenýl setið pýridóindólón, framleiðsla og meðferðarleg notkun þess.
NO20053825D0 (no)	2005-08-15	Thienopyridazinoner og deres anvendelse ved modulering av autoimmune sykdommer.
NL1027109A1 (nl)	2005-03-29	Verbinding en gebruik bij behandeling.
DE602005019913D1 (de)	2010-04-22	Therapeutische pyrazoloä3,4-büpyridine und -indazole
DK1680405T3 (da)	2009-05-04	Bengamidderivater og deres anvendelse til behandling af kræftsygdomme
ES1055129Y (es)	2004-02-01	Secadora-abrillantadora de cubiertos y similares.
EP1660088A4 (en)	2009-04-29	PYRIDOMORPHINANE, PYRIDAZINOMORPHINANE AND ITS USE
IS8057A (is)	2005-09-29	Hindrar á sýklín-háða kínasa, samsetningar og notkun tengd þeim
FI20020982A0 (fi)	2002-05-24	Autentikointimenetelmä ja -järjestely
NO20053189D0 (no)	2005-06-29	HVC-kombinasjonsterapi.
NO20055559D0 (no)	2005-11-24	Plugg og fremgangsmate ved bruk av samme
EP1615552A4 (en)	2006-11-29	SAPPHYRINE AND ITS USES

Legal Events

Date	Code	Title	Description
2010-08-23	FC2A	Withdrawal, rejection or dismissal of laid open patent application